Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
CVS Health
CVS
|
+$1.4B |
| 2 |
FedEx
FDX
|
+$1.08B |
| 3 |
Intel
INTC
|
+$866M |
| 4 |
Celanese
CE
|
+$758M |
| 5 |
Apple
AAPL
|
+$673M |
Top Sells
| 1 |
Humana
HUM
|
+$1.73B |
| 2 |
Comcast
CMCSA
|
+$1.49B |
| 3 |
Crown Castle
CCI
|
+$1.18B |
| 4 |
UnitedHealth
UNH
|
+$1.11B |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$972M |
Sector Composition
| 1 | Technology | 21.7% |
| 2 | Financials | 13.96% |
| 3 | Healthcare | 13.81% |
| 4 | Industrials | 12.74% |
| 5 | Communication Services | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
L3Harris
LHX
$52.7B
| $862K | ﹤0.01% |
4,953
-1,686
| -25% | -$294K |
|
427
Capital Group Global Growth Equity ETF
CGGO
$7.11B
| $736K | ﹤0.01% |
32,120
-724
| -2% | -$16.6K |
|
428
Capital Group Growth ETF
CGGR
$16.1B
| $506K | ﹤0.01% |
20,671
-53
| -0.3% | -$1.3K |
|
429
Capital Group Core Equity ETF
CGUS
$7.26B
| $411K | ﹤0.01% |
16,382
+1,382
| +9% | +$34.7K |
|
430
Diebold Nixdorf
DBD
$2.2B
| $346K | ﹤0.01% |
+18,269
| New | +$346K |
|
431
Vanguard FTSE All-World ex-US ETF
VEU
$50.1B
| $323K | ﹤0.01% |
6,201
+1,780
| +40% | +$92.6K |
|
432
Sociedad Química y Minera de Chile
SQM
$12.4B
| $252K | ﹤0.01% |
4,218
-3,495,844
| -100% | -$208M |
|
433
Momentus Inc. Warrant
MNTSW
$314
| $22.3K | ﹤0.01% |
2,225,000
| – | – |
|
434
Aptiv
APTV
$18B
| – | – |
-129,916
| Closed | -$13.3M |
|
435
Walt Disney
DIS
$208B
| – | – |
-2,682,873
| Closed | -$240M |
|
436
DexCom
DXCM
$29.6B
| – | – |
-2,340,342
| Closed | -$301M |
|
437
Enbridge
ENB
$107B
| – | – |
-1,482,712
| Closed | -$55.1M |
|
438
Enphase Energy
ENPH
$4.97B
| – | – |
-724,859
| Closed | -$121M |
|
439
Exelon
EXC
$43.9B
| – | – |
-3,628,215
| Closed | -$148M |
|
440
Gilead Sciences
GILD
$140B
| – | – |
-6,864
| Closed | -$529K |
|
|
441
Humana
HUM
$33.1B
| – | – |
-3,871,317
| Closed | -$1.73B |
|
442
Infosys
INFY
$70.1B
| – | – |
-9,852,748
| Closed | -$158M |
|
443
iShares Core S&P 500 ETF
IVV
$679B
| – | – |
-1,537
| Closed | -$677K |
|
444
Lockheed Martin
LMT
$110B
| – | – |
-162,317
| Closed | -$74.7M |
|
445
MaxLinear
MXL
$1.45B
| – | – |
-328,275
| Closed | -$10.4M |
|
446
Ultragenyx Pharmaceutical
RARE
$2.79B
| – | – |
-967,357
| Closed | -$44.6M |
|
|
NARI
447
DELISTED
Inari Medical, Inc. Common Stock
NARI
| – | – |
-44,300
| Closed | -$2.58M |
|
|
KKR.PRC
448
DELISTED
KKR & Co. Inc. 6.00% Series C Mandatory Convertible Preferred Stock
KKR.PRC
| – | – |
-1,845,318
| Closed | -$122M |
|
449
Nexa Resources
NEXA
$670M
| – | – |
-4,709,938
| Closed | -$22.9M |
|
450
NVR
NVR
$22.9B
| – | – |
-24,677
| Closed | -$157M |
|